Lakeway, TX -- (SBWIRE) -- 03/05/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Ferro Corporation (NYSE:FOE) shares increased 30.77% to $6.80 after A. Schulman Inc yesterday announced that it has made a proposal to the Board of Directors of Ferro Corp to acquire all of the outstanding shares of Ferro common stock for per-share consideration of $6.50, representing an estimated total enterprise value of approximately $855 million including total indebtedness. The offer represents a 25% premium over the closing price of Ferro common stock on March 1, 2013, and a 32% premium over the volume-weighted average trading price over the preceding 60-day period.
How Should Investors Trade FOE After The Solid Jump? Let’s Find Out Here
MBIA Inc. (NYSE:MBI) shares jumped 23.96% and closed at $12.78. The company yesterday won the dismissal of a lawsuit by Bank of America Corp and Societe Generale SA challenging its 2009 restructuring, sending the bond insurer's shares up 24 percent. Bank of America and Societe Generale, the French bank, were the only remaining plaintiffs among 18 financial companies that said the split defrauded policyholders such as themselves.
Additionally, MBI’s stock was upgraded by investment analysts at TheStreet from a “sell” rating to a “hold” rating in a note issued to investors on Mar. 1.
Is MBI Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here
NQ Mobile Inc (ADR) (NYSE:NQ) shares gained 16.96% to $8.07 after the Chinese software security company said it will provide its products to subscribers of America Movil SAB, the Mexican wireless carrier controlled by billionaire Carlos Slim. America Movil will begin offering NQ Mobile’s products for security, privacy and family protection to its 262 million subscribers in Latin America this year.
Is NQ Buy After The Recent Price Movement? Find Out Here
Theravance Inc (NASDAQ:THRX) shares increased 16.11% and closed at $24.29 on investor speculation that GlaxoSmithKline (GSK) Plc may purchase the remaining 73 percent of the company that it doesn’t already own. Glaxo, the U.K.’s largest drugmaker, may consider acquiring Theravance to fully control respiratory drugs the companies developed together, Piper Jaffray analysts said today in a note to clients.
Additionally, the company announced that Michael W. Aguiar, Theravance's Senior Vice President and Chief Financial Officer, is scheduled to present at The Boston Marriott Copley Place, Boston, MA on Tuesday, March 5, 2013 at 10:00 a.m. ET.
Is THRX Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here
vbtrendreport.com’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by vbtrendreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vbtrendreport.com does expect that investors will buy and sell securities based on information assembled and presented in vbtrendreport.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)